Sumitomo Life Insurance’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-1,989
Closed -$697K 288
2025
Q4
$697K Buy
1,989
+22
+1% +$7.43K 0.02% 227
2025
Q3
$636K Sell
1,967
-80
-4% -$24.9K 0.02% 226
2025
Q2
$796K Sell
2,047
-148
-7% -$59.5K 0.05% 194
2025
Q1
$955K Buy
2,195
+22
+1% +$8.83K 0.03% 183
2024
Q4
$802K Sell
2,173
-91
-4% -$38.1K 0.02% 207
2024
Q3
$1.18M Buy
2,264
+61
+3% +$32.6K 0.02% 176
2024
Q2
$1.19M Sell
2,203
-269
-11% -$142K 0.03% 165
2024
Q1
$1.28M Sell
2,472
-110
-4% -$54.7K 0.03% 164
2023
Q4
$1.22M Sell
2,582
-135
-5% -$62.4K 0.04% 160
2023
Q3
$1.18M Sell
2,717
-37
-1% -$16.8K 0.03% 152
2023
Q2
$1.22M Sell
2,754
-677
-20% -$312K 0.05% 157
2023
Q1
$1.58M Hold
3,431
0.13% 123
2022
Q4
$1.76M Hold
3,431
0.13% 110
2022
Q3
$1.56M Sell
3,431
-29
-0.8% -$13.9K 0.07% 113
2022
Q2
$1.67M Buy
3,460
+76
+2% +$37.6K 0.05% 119
2022
Q1
$1.66M Sell
3,384
-46
-1% -$21K 0.04% 140
2021
Q4
$1.59M Sell
3,430
-106
-3% -$44.6K 0.04% 154
2021
Q3
$1.32M Sell
3,536
-150
-4% -$57K 0.04% 174
2021
Q2
$1.41M Sell
3,686
-587
-14% -$224K 0.04% 174
2021
Q1
$1.53M Sell
4,273
-3,500
-45% -$1.13M 0.06% 175
2020
Q4
$2.5M Sell
7,773
-923
-11% -$283K 0.11% 91
2020
Q3
$2.34M Sell
8,696
-453
-5% -$122K 0.11% 100
2020
Q2
$2.41M Sell
9,149
-750
-8% -$200K 0.13% 90
2020
Q1
$2.25M Buy
9,899
+104
+1% +$28.3K 0.16% 92
2019
Q4
$2.96M Buy
9,795
+551
+6% +$152K 0.34% 82
2019
Q3
$2.22M Sell
9,244
-1,158
-11% -$317K 0.29% 100
2019
Q2
$2.94M Buy
10,402
+419
+4% +$114K 0.35% 78
2019
Q1
$2.87M Sell
9,983
-1,146
-10% -$331K 0.39% 78
2018
Q4
$2.92M Sell
11,129
-1,709
-13% -$470K 0.41% 72
2018
Q3
$3.52M Sell
12,838
-219
-2% -$56.9K 0.42% 71
2018
Q2
$3.11M Buy
13,057
+528
+4% +$122K 0.38% 80
2018
Q1
$2.75M Sell
12,529
-553
-4% -$130K 0.36% 88
2017
Q4
$2.94M Sell
13,082
-635
-5% -$135K 0.37% 87
2017
Q3
$2.6M Sell
13,717
-245
-2% -$46.6K 0.33% 100
2017
Q2
$2.63M Sell
13,962
-5,021
-26% -$902K 0.34% 96
2017
Q1
$3.14M Sell
18,983
-1,179
-6% -$188K 0.44% 63
2016
Q4
$2.9M Buy
20,162
+5,300
+36% +$710K 0.41% 69
2016
Q3
$1.86M Sell
14,862
-1,784
-11% -$230K 0.28% 115
2016
Q2
$2.19M Sell
16,646
-585
-3% -$80K 0.3% 107
2016
Q1
$2.4M Buy
17,231
+3,296
+24% +$440K 0.31% 103
2015
Q4
$1.94M Sell
13,935
-329
-2% -$45.3K 0.25% 135
2015
Q3
$2M Sell
14,264
-363
-2% -$54.6K 0.27% 122
2015
Q2
$2.4M Sell
14,627
-7,457
-34% -$1.19M 0.29% 111
2015
Q1
$3.41M Sell
22,084
-1,655
-7% -$236K 0.38% 79
2014
Q4
$2.98M Sell
23,739
-908
-4% -$112K 0.3% 110
2014
Q3
$2.95M Sell
24,647
-671
-3% -$77K 0.29% 107
2014
Q2
$2.72M Buy
25,318
+137
+0.5% +$14.1K 0.26% 140
2014
Q1
$2.51M Sell
25,181
-11,789
-32% -$1.07M 0.24% 152
2013
Q4
$3.42M Sell
36,970
-2,046
-5% -$182K 0.31% 115
2013
Q3
$3.26M Buy
39,016
+4,511
+13% +$387K 0.3% 113
2013
Q2
$2.82M Buy
+34,505
New +$2.58M 0.27% 130

Other funds holding ELV

Sumitomo Life Insurance's ELV Position: Q1 2026 in Review

Sumitomo Life Insurance sold out of Elevance Health (ELV) in Q1 2026, closing a stake of 1,989 shares — an estimated $697K sold.

Sumitomo Life Insurance first reported a position in ELV in Q2 2013 and held it in 51 quarters. The position peaked at $3.52M in Q3 2018. 1,464 funds tracked by Wall St. Rank hold ELV as of Q1 2026.

  • Sumitomo Life Insurance reported no remaining Elevance Health position as of Q1 2026 after selling out during the quarter.
  • Sumitomo Life Insurance sold 1,989 Elevance Health shares in Q1 2026, an estimated $697K.
  • Sumitomo Life Insurance first reported a position in Elevance Health in Q2 2013 and held it in 51 quarters.
  • Sumitomo Life Insurance's Elevance Health position peaked at $3.52M in Q3 2018.
  • 1,464 funds tracked by Wall St. Rank held Elevance Health as of Q1 2026.

Based on Sumitomo Life Insurance's 13F filing for Q1 2026, filed 12 May 2026.